| ALK

COVID-19 webinars

Last updated: 04.06.2021

Healthcare Professionals

Explore more information about allergy immunotherapy (AIT) and its long-term disease-modifying and protective effects, ALK’s movement from experience- to evidence-based AIT with clinical trials and real-world evidence, and our compliance with guidelines and sharing of clinical data. All collected for you as a healthcare professional with the purpose of improving the understanding of allergic disease, assisting prescriber decisions, and helping more people living with allergy.

We also present The Henning Løwenstein Research Award – an award to young scientists who has shown excellence within the field of allergy. 

Finally, you can read more about our work with a new allergy portal for healthcare proffesionals here.

Avatar

Allergy immunotherapy

AIT is the only treatment targeting the root cause of allergy – the immune system. Therefore, AIT has not only the capacity of improving symptoms and reducing the need for other medication, but also to induce specific tolerance beyond the duration of treatment, modify the course of the disease, and prevent development of new sensitisations and co-morbidities.

Avatar

Our data

In ALK, we focus on expanding the access to evidence-based AIT. We commit to investigating the safety and efficacy of specific treatment in controlled settings – clinical trials – and in uncontrolled settings – the real-world. This commitment offers the best of two worlds, assisting prescribers in treatment decisions and thereby helping people living with allergy.

Avatar

Henning Løwenstein Research Award

The Henning Løwenstein Research Award was established and dedicated to researcher Henning Løwenstein by ALK on his 25th anniversary of work at the company. This biennial award is given to a young scientist who has shown excellence within the field of allergy research.

New allergy portal for healthcare professionals

We are currently building a new portal for healthcare professionals, granting access to comprehensive educational resources and clinical support within the most common respiratory allergies. This will be launched in 2025 and continuously expanded with the latest medical information. Please keep posted.

In the meantime, you as a healthcare professional are welcome to register as a user and get access to The Henning Løwenstein Research Award ceremonies of 2024 and 2021 as well as educational and clinical webinars with medical experts' perspectives and panel discussions within the field of respiratory allergy.

Thank you for your patience.


Henning Løwenstein Research Award ceremonies

Watch the 2024 and 2021 Henning Løwenstein Research Award ceremonies including lectures by the winners Kelly Bruton (2024) and Julia Esser-von Bieren (2021) as well as list of previous ceremonies and winners of the award.


Medical events

Get access to interactive educational and clinical webinars in which medical experts within the field of respiratory allergy share their perspectives and discuss AIT, management of patients with respiratory allergies, and clinical practices.

Last updated: 12.12.2024

Allergy immunotherapy

Healthcare professionals

Allergy immunotherapy

Targets the root cause of allergy by stimulating an immune response

Allergy immunotherapy (AIT) is the only treatment of allergic disease that addresses the underlying cause of the disease: the immune system. Therefore, it is also the only treatment capable of modifying the course of the disease.

It works by administering repeated doses of the specific allergen that the patient is allergic to. This stimulates an immune response in the body, which causes the patient to build up immunological tolerance against the given allergen. 

AIT is proven not only to improve the patient’s symptoms and need for symptom-relieving medication, but also to induce specific tolerance beyond the duration of the treatment. By targeting the specific allergen that triggers a patient’s symptoms, AIT inhibits the occurrence of both seasonal and perennial allergic reactions. 

Disease-modifying and protective effect

To achieve long-term sustained effect, where the benefits of the treatment continue after the treatment has ended, it is recommended to treat with AIT for three to five years. Because of the induced immunological tolerance, AIT not only provides long-term relief of symptoms and improvement of quality of life, but also has the potential of preventing onset of new sensitisations, allergic conditions, and progression into asthma as well as impacting asthma severity. Neither of these disease-modifying and protective effects are possible with symptom-relieving medication. 

Why has AIT disease-modifying effect?

References
  • Alvaro-Lozano M et al. EAACI Allergen Immunotherapy User's Guide. Pediatr Allergy Immunol. 2020;31 Suppl 25(Suppl 25):1-101
  • Durham SR et al. J Allergy Clin Immunol. 2012;129(5):717-725; 2
  • Global Atlas of Allergy, EAACI 2014
  • Larsen JN et al. Drug Discov Today 2016:21(1):26-37
  • Penagos M, Durham S. Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy. Allergy Asthma Proc 202243(4):292-298
  • Shamji MH et al. J Allergy Clin Immunol 2017;140(6):1485-1498
  • Valovirta E et al. J Allergy Clin Immunol. 2018;141(2):529-38
Last updated: 17.12.2024

Production

A unique production approach

Production and quality standards

From pollens to finished products

  • Raw materials
    Raw materials
    Natural allergens, such as grass pollen and house dust mites, are the main ingredients of our products. Every year the company grows, collects or harvests several tonnes of allergens.
  • API Production
    API Production
    Handling natural allergens requires thorough analysis, standardisation and quality control processes. This ensures that the biological variation that will always be present in a natural product does not affect the quality of the finished product. It also ensures that it is possible to reproduce the product at any time.
  • Formulation
    Finished production
    The active pharmaceutical ingredient is purified in our own production facilities. Subsequently, the active ingredient is formulated as injections, sublingual drops or sublingual tablets.
  • Distribution
    Packaging and distribution
    Following careful quality control, the finished products are labelled, packaged and distributed.
Raw materials Natural allergens, such as grass pollen and house dust mites, are the main ingredients of our products. Every year the company grows, collects or harvests several tonnes of allergens.
API Production Handling natural allergens requires thorough analysis, standardisation and quality control processes. This ensures that the biological variation that will always be present in a natural product does not affect the quality of the finished product. It also ensures that it is possible to reproduce the product at any time.
Finished production The active pharmaceutical ingredient is purified in our own production facilities. Subsequently, the active ingredient is formulated as injections, sublingual drops or sublingual tablets.
Packaging and distribution Following careful quality control, the finished products are labelled, packaged and distributed.
  • Raw materials
    Raw materials
    Natural allergens, such as grass pollen and house dust mites, are the main ingredients of our products. Every year the company grows, collects or harvests several tonnes of allergens.
  • API Production
    API Production
    Handling natural allergens requires thorough analysis, standardisation and quality control processes. This ensures that the biological variation that will always be present in a natural product does not affect the quality of the finished product. It also ensures that it is possible to reproduce the product at any time.
  • Formulation
    Finished production
    The active pharmaceutical ingredient is purified in our own production facilities. Subsequently, the active ingredient is formulated as injections, sublingual drops or sublingual tablets.
  • Distribution
    Packaging and distribution
    Following careful quality control, the finished products are labelled, packaged and distributed.

Our quality culture

The heart of everything we do.

Quality is key at a pharma company like ALK. It is our license to operate, a safety net for our patients and a necessity for our continued growth as a company.

Therefore, quality is also a strategic priority at ALK. We take our responsibility for patient safety and public health very seriously, and we will continue to increase our investments in time, money and energy into making sure that we can continue to deliver high, consistent quality products to the many people with allergy, who rely on our solutions.

At ALK, quality is built upon two pillars – our quality culture and our quality system.

  • Patient safety, product quality and efficacy, compliance, data integrity and stakeholder expectations
  • That quality is built into our products, processes, services, and systems
  • Continuous improvement of our operations, processes, and products

ALK’s quality commitment 

By maintaining a strong focus on quality, we uphold our resilient heritage at ALK as a pioneer committed to helping people living with allergy. We remain committed to:

  • Ensuring that all employees have the appropriate skills and are sufficiently trained and competent to perform their work assignments
  • Using a risk-based process approach to integrate quality into the development and production of our products and our complementary services
  • Centering our approach on quality and ethical principles with emphasis on patient engagement, science, and medical data. This to ensure that we deliver safe and efficacious products and valuable information to guide healthcare professionals and people living with allergy
  • Complying with regulatory and business requirements, to meet stakeholder expectations and maintain and continuously improve the ALK quality system.
Last updated: 05.07.2019

Emergency medicine

Anaphylaxis

Treatment of acute allergic reactions

If you are allergic, exposure to specific food or bee og wasp sting may trigger an acute allergic reaction

Learn more about how we collect, extract and process venom from bees and wasps to create venom allergy treatments.

Video file
Last updated: 05.07.2019

Allergy vaccines

Allergy vaccines

Reprogramming the immune system

Our solution is founded on evidence-based products that gradually build up tolerance to allergens.
Last updated: 30.04.2020

Diagnostics

Know your condition

Diagnosing allergy

The first step in being able to optimally treat any allergy is getting a definitive diagnosis.
ALK manufactures allergen extracts for use in the diagnosis of specific allergies, for instance: in skin prick tests.

In conjunction with the patient’s medical history, a skin prick test can show whether a person has an allergy and, if so, which particular allergen is responsible for their symptoms.

The first step to optimally treating any allergy is a formal diagnosis.

This can be established by reviewing any relevant disease history and symptoms, and can be confirmed by allergy testing.

Last updated: 05.07.2019

Consumer healthcare

Consumer healthcare

Making life with allergy simple

By collecting information and the latest and most trusted solutions together in one place, we want to make allergy surprisingly simple to manage.
Allergy is rarely a life-threatening condition, but it can often be life changing. Our aim is to help you manage that change practically and positively.

Allergy is the most widespread chronic disease in the world and, while ALK is an established expert in the field, just 1% of people with allergy currently receive the allergy immunotherapy products that form the core of our portfolio. 

As a result, many in the other 99% may not be aware of the full range of treatment options available to them. Frequently, these people are undiagnosed, suffering in silence, or self-managing their condition with various over-the-counter products and medicines.

Those who eventually find their way to allergy immunotherapy often do so after many years of failed attempts to treat their allergy with other types of product.

Last updated: 16.12.2020

Burden of allergic disease

High costs

The consequences of allergic disease

Allergic rhinitis and allergic asthma are an important cause of loss of productivity
Last updated: 09.11.2016

Living with allergy

A modern condition

Impact on daily life

Almost 70% of people who are diagnosed with allergic rhinitis feel that the condition limits their way of life. Reprogramming their immune system to improve its tolerance of specific allergens can help.

Avoidance is difficult

If you suffer from house dust mite allergy it can be hard to escape its symptoms. House dust mites are present everywhere: at work, at home, and particularly in the bedroom. Even going outdoors may not help as, once your airways become inflamed, the symptoms can continue no matter where you go.
Last updated: 09.11.2016